Cargando…
Policy during coronavirus disease 2019 (COVID-19) pandemic: a protector for acute exacerbation of COPD (AECOPD) patients?
Autores principales: | Zeng, Yuqin, Zhou, Zijing, Chen, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182511/ https://www.ncbi.nlm.nih.gov/pubmed/34164210 http://dx.doi.org/10.21037/jtd-20-3342 |
Ejemplares similares
-
Is Acute Exacerbation of COPD (AECOPD) Related to Viral Infection Associated with Subsequent Mortality or Exacerbation Rate?
por: Kherad, Omar, et al.
Publicado: (2014) -
Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines
por: Brennan, Michelle, et al.
Publicado: (2022) -
Acute exacerbations of copd (AECOPD) in the emergency room (ER): prognostic value of proadrenomedulline (PROADM)
por: Dres, M, et al.
Publicado: (2015) -
Psychosis and pandemics: Is there a secret protector?
por: Vukojević, Jakša, et al.
Publicado: (2020) -
Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis
por: Hoult, George, et al.
Publicado: (2022)